Email
Print
Motion Sickness Treatment Market - Forecast(2024 - 2030)
Motion Sickness Treatment Market Overview:
Motion Sickness
Market size is valued at $402.4 Million
in 2022 and is expected to reach a value of $876.8 Million by 2030 at a CAGR of
3.4% during the forecast period 2023-2030. The motion sickness treatment market addresses the needs of individuals who suffer from motion sickness, a condition characterized by discomfort, dizziness, and nausea when exposed to certain types of motion. This market focuses on providing solutions and treatments to alleviate or prevent motion sickness symptoms, enabling affected individuals to have a more comfortable and enjoyable experience during travel or motion-related activities. According to
Cleveland Clinic, an estimated one in three people get motion sickness at some
point.
The market encompasses a wide range of treatment options for motion sickness. Medications are a commonly utilized approach, with antihistamines like dimenhydrinate and meclizine being widely prescribed to reduce nausea and dizziness. Additionally, medications like scopolamine patches can be used to alleviate symptoms. Non-pharmacological remedies, such as acupressure wristbands and specialized motion sickness relief devices like virtual reality headsets, are also available to help manage symptoms.
The motion sickness treatment market is influenced by various factors. The prevalence of motion sickness among the population, increasing demand for effective treatments, advancements in technology, and the growth of the travel and tourism industry all contribute to market dynamics. For example,
according to data released by UNWTO in November 2022, an estimated 700 million
tourists travelled abroad between January and September this year, compared to
the number of tourists who travelled during the same period in 2021. It has
more than doubled. Furthermore, according to the same source, more than 477
million tourists travelled across Europe from January to September 2022, an 81%
increase from pre-pandemic levels. Pharmaceutical companies, medical device
manufacturers, research institutions, healthcare providers, and retail
pharmacies are among the key players in this market, working together to
provide innovative solutions and improve the quality of care for individuals
with motion sickness
Market Snapshot:
Motion Sickness Treatment Market - Report Coverage:
The “Motion Sickness Treatment Market Report - Forecast (2023-2030)” by IndustryARC, covers an in-depth analysis of the following segments in the Motion Sickness Treatment Market.
| Attribute | Segment |
|---|---|
By Treatment Type |
|
By Route of Administration |
|
By Distribution Channel |
|
By End User |
|
By Geography |
|
Motion Sickness Treatment Market - Top Trends
Technological advancements: Advancements in technology have led to the development of innovative motion sickness treatments. For example, wearable devices such as wristbands or patches that use electric stimulation or acupressure to alleviate motion sickness symptoms have gained popularity.
Virtual reality (VR) as a treatment option: Virtual reality has shown promise in managing motion sickness. By exposing individuals to virtual environments that mimic real-world motion, it helps desensitize them to the triggers of motion sickness. VR-based therapies are being explored as a potential treatment option.
Pharmacological interventions: The pharmaceutical industry continues to invest in the development of effective medications for motion sickness. These include antihistamines, anticholinergics, and other drugs that target the underlying causes of motion sickness. Ongoing research aims to improve the efficacy and reduce the side effects associated with these medications.
Natural remedies and alternative therapies: There is growing interest in natural remedies and alternative therapies for motion sickness. Ginger, for example, has been studied for its potential antiemetic properties and may help alleviate symptoms. Other alternative therapies, such as acupuncture and aromatherapy, are also being explored for their potential benefits in managing motion sickness.
Personalized treatments: As our understanding of motion sickness and its underlying mechanisms improves, there is a focus on developing personalized treatment approaches. Factors such as an individual's susceptibility to motion sickness, the specific triggers they experience, and their overall health profile can help tailor treatment plans to provide better outcomes.
Motion Sickness Treatment Market - Company Product Analysis
GlaxoSmithKline (GSK): Transderm Scop is a prescription patch that delivers scopolamine, an anticholinergic medication, through the skin to prevent motion sickness. It works by blocking certain signals in the brain that cause nausea and vomiting. The patch is typically applied behind the ear and provides continuous relief for up to 3 days.
Prestige Brands Holdings: Dramamine is an over-the-counter medication used to prevent and treat motion sickness. It contains the active ingredient dimenhydrinate, which is an antihistamine that helps reduce symptoms like nausea, vomiting, and dizziness. Dramamine is available in various forms, including tablets, chewable tablets, and liquid.
Reliefband Technologies: Reliefband is a wearable device that uses neuromodulation technology to alleviate motion sickness symptoms. It applies gentle electrical stimulation to the median nerve on the underside of the wrist, which helps to rebalance the signals in the body that cause nausea and vomiting. Reliefband is adjustable and can be worn on either wrist.
The Seaplanet Company: The Boarding Ring is a wristband-type device designed to prevent motion sickness. It works by stimulating the P6 acupuncture point on the wrist using gentle pressure. The device is adjustable and reusable, and it aims to provide relief from symptoms such as nausea, vomiting, and dizziness.
Cinnagen Co. Ltd.: Cinnaserin is an oral medication developed by Cinnagen Co. Ltd. for the treatment of motion sickness. It contains the active ingredient cyclizine, which is an antihistamine that helps to reduce nausea and vomiting. Cinnaserin is available in tablet form and is primarily marketed in Iran.
Key Market Players:
Product/Service launches, approvals, patents and events, acquisitions, partnerships and collaborations are key strategies adopted by players in the Motion Sickness Treatment Market. The top 10 companies in this industry are listed below:
- Prestige Consumer Healthcare Inc.
- Baxter International Inc.
- Novartis AG
- Myungmoon Pharm Co Ltd
- Abbott Laboratories
- Sun Pharmaceutical Industries Ltd.
- Viatris Inc.
- WellSpring Pharmaceutical Corporation
- Zydus Lifesciences Limited
- CVS Health
Scope of Report:
| Report Metric | Details |
|---|---|
Base Year Considered | 2022 |
Forecast Period | 2023–2030 |
CAGR | 3.4% |
Market Size in 2030 | $876.8 Million |
Segments Covered | By Treatment Type, Distribution Channel, Route of Administration, and Region |
Geographies Covered | North America (U.S., Canada and Mexico), Europe (Germany, France, UK, Italy, Spain, Russia and Rest of Europe), Asia-Pacific (China, Japan, South Korea, India, Australia, New Zealand and Rest of Asia-Pacific), South America (Brazil, Argentina, Chile, Colombia and Rest of South America), Rest of the World (Middle East and Africa). |
Key Market Players |
|
For more Lifesciences and Healthcare Market reports, please click here
1. Motion Sickness Treatment Market - Overview
1.1 Definitions and Scope
2. Motion Sickness Treatment Market - Executive Summary
3. Motion Sickness Treatment Market - Comparative Analysis
3.1 Company Benchmarking - Key Companies
3.2 Global Financial Analysis - Key Companies
3.3 Market Share Analysis - Key Companies
3.4 Patent Analysis
3.5 Pricing Analysis
4. Motion Sickness Treatment Market - Start-up Companies Scenario (Premium)
4.1 Key Start-up Company Analysis by
4.2 Investment
4.3 Revenue
4.4 Venture Capital and Funding Scenario
5. Motion Sickness Treatment Market – Market Entry Scenario Premium (Premium)
5.1 Regulatory Framework Overview
5.2 New Business and Ease of Doing Business Index
5.3 Case Studies of Successful Ventures
6. Motion Sickness Treatment Market - Forces
6.1 Market Drivers
6.2 Market Constraints
6.3 Market Challenges
6.4 Porter's Five Force Model
6.5 Bargaining Power of Suppliers
6.6 Bargaining Powers of Customers
6.7 Threat of New Entrants
6.8 Rivalry Among Existing Players
6.9 Threat of Substitutes
7. Motion Sickness Treatment Market – Strategic Analysis
7.1 Value Chain Analysis
7.2 Opportunities Analysis
7.3 Market Life Cycle
8. Motion Sickness Treatment Market – By Treatment Type (Market Size – $Million/$Billion)
8.1 Antihistamines
8.1.1 Market Size and Forecast, By Region
8.1.2 Market Share Analysis, By Country
8.2 Anticholinergics
8.2.1 Market Size and Forecast, By Region
8.2.2 Market Share Analysis, By Country
8.3 Others
8.3.1 Market Size and Forecast, By Region
8.3.2 Market Share Analysis, By Country
9. Motion Sickness Treatment Market – By Route of Administration (Market Size – $Million/$Billion)
9.1 Oral
9.1.1 Market Size and Forecast, By Region
9.1.2 Market Share Analysis, By Country
9.2 Transdermal
9.2.1 Market Size and Forecast, By Region
9.2.2 Market Share Analysis, By Country
9.3 Others
9.3.1 Market Size and Forecast, By Region
9.3.2 Market Share Analysis, By Country
10. Motion Sickness Treatment Market – By Distribution Channel (Market Size – $Million/$Billion)
10.1 Hospital Pharmacies
10.1.1 Market Size and Forecast, By Region
10.1.2 Market Share Analysis, By Country
10.2 Drug Store and Retail Pharmacies
10.2.1 Market Size and Forecast, By Region
10.2.2 Market Share Analysis, By Country
10.3 Online Pharmacies
10.3.1 Market Size and Forecast, By Region
10.3.2 Market Share Analysis, By Country
11. Motion Sickness Treatment Market – By End User (Market Size – $Million/$Billion)
11.1 Hospitals
11.1.1 Market Size and Forecast, By Region
11.1.2 Market Share Analysis, By Country
11.2 Clinics
11.2.1 Market Size and Forecast, By Region
11.2.2 Market Share Analysis, By Country
11.3 Pharmacies
11.3.1 Market Size and Forecast, By Region
11.3.2 Market Share Analysis, By Country
11.4 Cruise Ships and Airlines
11.4.1 Market Size and Forecast, By Region
11.4.2 Market Share Analysis, By Country
12. Motion Sickness Treatment Market – by Geography (Market Size – $Million/$Billion)
12.1 North America
12.1.1 The U.S.
12.1.2 Canada
12.1.3 Mexico
12.2 Europe
12.2.1 UK
12.2.2 Germany
12.2.3 France
12.2.4 Italy
12.2.5 Spain
12.2.6 Russia
12.2.7 Rest of Europe
12.3 Asia-Pacific
12.3.1 China
12.3.2 India
12.3.3 Japan
12.3.4 South Korea
12.3.5 Australia & New Zealand
12.3.6 Rest of Asia-Pacific
12.4 South America
12.4.1 Brazil
12.4.2 Argentina
12.4.3 Chile
12.4.4 Colombia
12.4.5 Rest of South America
12.5 Rest of the World
12.5.1 Middle East
12.5.2 Africa
13. Motion Sickness Treatment Market – Entropy
14. Motion Sickness Treatment Market – Industry/Segment Competition Landscape Premium
14.1 Market Share Analysis
14.1.1 Market Share by Product Type – Key Companies
14.1.2 Market Share by Region – Key Companies
14.1.3 Market Share by Country – Key Companies
14.2 Competition Matrix
14.3 Best Practices for Companies
15. Motion Sickness Treatment Market – Key Company List by Country Premium Premium
16. Motion Sickness Treatment Market - Company Analysis
16.1 Prestige Consumer Healthcare Inc.
16.2 Baxter International Inc.
16.3 Novartis AG
16.4 Myungmoon Pharm Co Ltd
16.5 Abbott Laboratories
16.6 Sun Pharmaceutical Industries Ltd.
16.7 Viatris Inc.
16.8 WellSpring Pharmaceutical Corporation
16.9 Zydus Lifesciences Limited
16.10 CVS Health
• "Financials to the Private Companies would be provided on best-effort basis."
Connect with our experts to get customized reports that best suit your requirements. Our
reports include global-level data, niche markets and competitive landscape.
The Motion Sickness Treatment is forecast to grow at 3.4% during the forecast period 2023-2030.
Global Motion Sickness Treatment Market size is estimated to reach $876.8 Million by 2023.
The leading players in the Motion Sickness Treatment Market are Prestige Consumer Healthcare Inc., Baxter International Inc., Novartis AG, Abbott Laboratories.